Skip to Content

M 944 (Divalproex Sodium Delayed-Release 250 mg)

This pill with imprint "M 944" is Blue, Round and has been identified as Divalproex sodium delayed-release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release

Imprint:
M 944
Strength:
250 mg
Color:
Blue
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
ferrosoferric oxide
silicon dioxide
copovidone
croscarmellose sodium
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
lactose monohydrate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polydextrose
polyethylene glycol
polysorbate 80
polyvinyl alcohol
propylene glycol
sodium hydroxide
magnesium silicate
titanium dioxide
triacetin
triethyl citrate
Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Labelers / Repackagers:
NDC CodeLabeler / Repackager
51079-0474 UDL Laboratories Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide